Home Merck & Co., Inc. (MRK) Price Target Lowered to $65.00 at Argus
 

Keywords :   


Merck & Co., Inc. (MRK) Price Target Lowered to $65.00 at Argus

2015-11-30 07:37:30| Biotech - Topix.net

The firm presently has a "buy" rating on the stock. Argus' price target indicates a potential upside of 20.46% from the company's current price.

Tags: to price target lowered

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
05.07Tropical Storm Beryl Graphics
05.07Atlantic Tropical Weather Outlook
05.07Tropical Storm Beryl Public Advisory Number 28A
05.07Summary for Tropical Storm Beryl (AT2/AL022024)
05.07Eastern North Pacific Tropical Weather Outlook
05.07Tubi and Pluto lead U.S. surge in free streaming
05.07Tubi free streaming service launches in the UK
05.07Simplestream reveals preferred technology partnership with Freely
More »